Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Bista

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2013
MDMX contains an autoinhibitory sequence elementMichal Bista, Miriana Petrovich, Alan R Fersht
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2012
Domain-domain interactions in full-length p53 and a specific DNA complex probed by methyl NMR spectroscopyMichal Bista, Stefan M Freund, Alan R Fersht
Journal of the American Chemical Society|May 9, 2009
Robust NMR screening for lead compounds using tryptophan-containing proteinsMichal Bista, Kaja Kowalska, Weronika Janczyk, et al.
Chemical Biology & Drug Design|May 25, 2010
1,4-Thienodiazepine-2,5-diones via MCR (I): synthesis, virtual space and p53-Mdm2 activityYijun Huang, Siglinde Wolf, Michal Bista, et al.
Acta Biochimica Polonica|September 5, 2008
A novel member of the thermolysin family, cloning and biochemical characterization of metalloprotease from Staphylococcus pseudintermediusBenedykt Wladyka, Michal Bista, Artur J Sabat, et al.
British Journal of Pharmacology|November 22, 2017
Quantifying the relationship between inhibition of VEGF receptor 2, drug-induced blood pressure elevation and hypertensionTeresa Collins, Kelly Gray, Michal Bista, et al.
Plos One|March 22, 2016
MTH1 Substrate Recognition--An Example of Specific PromiscuityJ Willem M Nissink, Michal Bista, Jason Breed, et al.
Nature Communications|August 19, 2020
CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAsMatthew A Coelho, Etienne De Braekeleer, Mike Firth, et al.
Angewandte Chemie (International Ed. in English)|June 25, 2010
Robust generation of lead compounds for protein-protein interactions by computational and MCR chemistry: p53/Hdm2 antagonistsAnna Czarna, Barbara Beck, Stuti Srivastava, et al.
Acta Crystallographica. Section D, Structural Biology|November 7, 2019
Antibody fragments structurally enable a drug-discovery campaign on the cancer target Mcl-1Jakub Luptak, Michal Bista, David Fisher, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2013
MDMX contains an autoinhibitory sequence elementMichal Bista, Miriana Petrovich, Alan R Fersht
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2012
Domain-domain interactions in full-length p53 and a specific DNA complex probed by methyl NMR spectroscopyMichal Bista, Stefan M Freund, Alan R Fersht
Journal of the American Chemical Society|May 9, 2009
Robust NMR screening for lead compounds using tryptophan-containing proteinsMichal Bista, Kaja Kowalska, Weronika Janczyk, et al.
Chemical Biology & Drug Design|May 25, 2010
1,4-Thienodiazepine-2,5-diones via MCR (I): synthesis, virtual space and p53-Mdm2 activityYijun Huang, Siglinde Wolf, Michal Bista, et al.
Acta Biochimica Polonica|September 5, 2008
A novel member of the thermolysin family, cloning and biochemical characterization of metalloprotease from Staphylococcus pseudintermediusBenedykt Wladyka, Michal Bista, Artur J Sabat, et al.
British Journal of Pharmacology|November 22, 2017
Quantifying the relationship between inhibition of VEGF receptor 2, drug-induced blood pressure elevation and hypertensionTeresa Collins, Kelly Gray, Michal Bista, et al.
Plos One|March 22, 2016
MTH1 Substrate Recognition--An Example of Specific PromiscuityJ Willem M Nissink, Michal Bista, Jason Breed, et al.
Nature Communications|August 19, 2020
CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAsMatthew A Coelho, Etienne De Braekeleer, Mike Firth, et al.
Angewandte Chemie (International Ed. in English)|June 25, 2010
Robust generation of lead compounds for protein-protein interactions by computational and MCR chemistry: p53/Hdm2 antagonistsAnna Czarna, Barbara Beck, Stuti Srivastava, et al.
Acta Crystallographica. Section D, Structural Biology|November 7, 2019
Antibody fragments structurally enable a drug-discovery campaign on the cancer target Mcl-1Jakub Luptak, Michal Bista, David Fisher, et al.
Pageof 3